Rafferty Asset Management
IART icon

Rafferty Asset Management’s Integra LifeSciences IART Stock Holding History

Rafferty Asset Management’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-9,558
Closed -$533K – 828
2019
Q1 		$533K Buy
+9,558
New +$487K 0.01% 658
2018
Q1 		– Sell
-16,627
Closed -$796K – 700
2017
Q4 		$796K Buy
16,627
+1,923
+13% +$94.1K 0.01% 482
2017
Q3 		$742K Buy
+14,704
New +$755K 0.02% 462

Other funds holding IART

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Rafferty Asset Management's IART Position: Q2 2019 in Review

Rafferty Asset Management sold out of Integra LifeSciences (IART) in Q2 2019, closing a stake of 9,558 shares — an estimated $533K sold.

Rafferty Asset Management first reported a position in IART in Q3 2017 and held it in 3 quarters. The position peaked at $796K in Q4 2017. 262 funds tracked by Wall St. Rank hold IART as of Q2 2019.

  • Rafferty Asset Management reported no remaining Integra LifeSciences position as of Q2 2019 after selling out during the quarter.
  • Rafferty Asset Management sold 9,558 Integra LifeSciences shares in Q2 2019, an estimated $533K.
  • Rafferty Asset Management first reported a position in Integra LifeSciences in Q3 2017 and held it in 3 quarters.
  • Rafferty Asset Management's Integra LifeSciences position peaked at $796K in Q4 2017.
  • 262 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2019.

Based on Rafferty Asset Management's 13F filing for Q2 2019, filed 9 Aug 2019.